Vikram Sengupta MD Chief Medical Officer
Chief Medical Officer—Direct Biologics, LLC Owner & Chief Medical Officer—Thrivewell Infusion, LLC
Join to View Full Profile
333 E Shore Rd Ste 201Manhasset, NY 11030
Phone+1 212-803-3339
Dr. Sengupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2011 - 2014
Yale School of MedicineClass of 2011
Cornell UniversityBA, Neurobiology and Behavior, 2004
Publications & Presentations
PubMed
- 1 citationsA novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS).Erik Osborn, John T Ransom, Anastasiya Shulman, Vikram Sengupta, Mohammed Choudhry
Respiratory Medicine Case Reports. 2024-01-01 - 46 citationsBone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosin...Amy L Lightner, Vikram Sengupta, Sascha Qian, John T Ransom, Sam Suzuki
Chest. 2023-12-01 - 17 citationsResponse to Lim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19".Vikram Sengupta, Sascha Sengupta, Angel Lazo, Kevin C. Hicok, Timothy A. Moseley
Stem Cells and Development. 2020-07-09
Authored Content
- Biologic Therapies 1019/13/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
